[Ethanol and puromycin C, 2 mutually augmenting factors in the pathogenesis of fatty liver].
D000273:Adipose Tissue / Q000032:analysis; D000818:Animals; D004357:Drug Synergism; D004822:Epididymis / Q000032:analysis; D000431:Ethanol / Q000008:administration & dosage*; D005227:Fatty Acids / Q000032:analysis; D005234:Fatty Liver / Q000139:chemically induced*; D005260:Female; D005990:Glycerol / Q000032:analysis; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008099:Liver / Q000032:analysis / Q000378:metabolism; D008297:Male; D051379:Mice; D014176:Protein Biosynthesis; D011506:Proteins / Q000032:analysis; D011691:Puromycin / Q000008:administration & dosage*
D005227:Fatty Acids; D011506:Proteins; D000431:Ethanol; D011691:Puromycin; D005990:Glycerol
Alkohol und Puromycin C, zwei sich verstärkende Faktoren bei der Entstehung der Fettleber.